TP53 and acute myeloid leukemia: NPM1 mutations are always heterozygous77 and it is hypothesized that the NPM1-mutated AML cells might be vulnerable to drugs that trigger a nucleolar stress response, because it contains a low level of non-mutant NPM1 and because p53 in these cells is not mutated78.